Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Azithromycin 250 mg Tablets in Healthy Chinese Subjects
NCT03353480Phase 1Completed
- Sponsor
- Pfizer
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azithromycin in bacterial infection (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Serum Concentration-Time Curve from Time Zero to 72 Hours and Maximum Serum Concentration. Started Dec 2017; status: completed.
02
Drugs
azithromycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03353480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353480.